A carregar...
Regarding “TELEPRO: Patient‐Reported Carcinoid Syndrome Symptom Improvement Following Initiation of Telotristat Ethyl in the Real World”
This letter to the editor, regarding the reported results of the TELEPRO study by Strosberg et al., provides real‐world support of the benefit of telotristat ethyl for symptoms of carcinoid syndrome.
Na minha lista:
| Publicado no: | Oncologist |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley & Sons, Inc.
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7356703/ https://ncbi.nlm.nih.gov/pubmed/32420675 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2020-0158 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|